Black Rock Petroleum Co Discloses Allegations Involving Lotus Bio-Technology

What Happened Black Rock Petroleum Co filed a Form 8-K on September 16, 2026 (Accession No. 0001171520-26-000264) under Item 8.01 “Other Events” to disclose matters involving Lotus Bio-Technology Development Corp. The filing notes allegations concerning Lotus Bio‑Technology Development Corp but makes clear those allegations have not been proven in court. The filing does not report earnings, executive changes, or other financial measures.

Key Details

• Filing date: September 16, 2026; Form 8-K, Item 8.01 (Accession No. 0001171520-26-000264).
• Subject: Allegations involving Lotus Bio‑Technology Development Corp disclosed by Black Rock Petroleum Co.
• Legal status: The allegations referenced have not been proven in court.
• History: The filing notes that earlier filings dating back to August 2022 may or may not have included this disclosure.

Why It Matters This 8-K signals a legal or reputational matter involving Lotus Bio‑Technology that Black Rock Petroleum deemed material enough to disclose, but it does not establish wrongdoing. For investors, the key takeaways are that details are limited, outcomes are uncertain, and you should watch for follow-up filings or court developments that could affect valuation or risk.